
Connor J. Tremarche
Examiner (ID: 13675)
| Most Active Art Unit | 3746 |
| Art Unit(s) | 3746, 3762 |
| Total Applications | 715 |
| Issued Applications | 414 |
| Pending Applications | 98 |
| Abandoned Applications | 218 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9477171
[patent_doc_number] => 20140134634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-15
[patent_title] => 'METHOD FOR DETERMINING DEPRESSION, KIT FOR ANALYZING SEROTONIN TRANSPORTER, AND KIT FOR ANALYZING UBIQUITINATED SEROTONIN TRANSPORTER IN BLOOD'
[patent_app_type] => utility
[patent_app_number] => 14/233374
[patent_app_country] => US
[patent_app_date] => 2012-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14667
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14233374
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/233374 | Method for determining depression, kit for analyzing serotonin transporter, and kit for analyzing ubiquitinated serotonin transporter in blood | Jul 18, 2012 | Issued |
Array
(
[id] => 9771795
[patent_doc_number] => 20140295458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-02
[patent_title] => 'METHOD OF REVERSIBLY STAINING A TARGET CELL'
[patent_app_type] => utility
[patent_app_number] => 14/234463
[patent_app_country] => US
[patent_app_date] => 2012-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14640
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 46
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14234463
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/234463 | Method of reversibly staining a target cell | Jul 16, 2012 | Issued |
Array
(
[id] => 9771805
[patent_doc_number] => 20140295469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-02
[patent_title] => 'In Vitro Assessment of Cardiovascular Events by Assay for Neo-Eptitopes of Titin Protein'
[patent_app_type] => utility
[patent_app_number] => 14/232405
[patent_app_country] => US
[patent_app_date] => 2012-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3806
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14232405
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/232405 | In vitro assessment of cardiovascular events by assay for neo-eptitopes of titin protein | Jul 5, 2012 | Issued |
Array
(
[id] => 8586157
[patent_doc_number] => 20130004977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-03
[patent_title] => 'MEASURING CIRCULATING THERAPEUTIC ANTIBODY, ANTIGEN AND ANTIGEN/ANTIBODY COMPLEXES USING ELISA ASSAYS'
[patent_app_type] => utility
[patent_app_number] => 13/543560
[patent_app_country] => US
[patent_app_date] => 2012-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 16839
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13543560
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/543560 | Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays | Jul 5, 2012 | Issued |
Array
(
[id] => 8489473
[patent_doc_number] => 20120288880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-15
[patent_title] => 'METHODS AND COMPOSITIONS FOR DIAGNOSIS OR PROGNOSIS OF CARDIOVASCULAR DISEASE'
[patent_app_type] => utility
[patent_app_number] => 13/543745
[patent_app_country] => US
[patent_app_date] => 2012-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 19680
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13543745
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/543745 | Methods and compositions for diagnosis or prognosis of cardiovascular disease | Jul 5, 2012 | Issued |
Array
(
[id] => 8821482
[patent_doc_number] => 20130122527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-16
[patent_title] => 'Methods and Compositions for Monitoring and Risk Prediction in Cardiorenal Syndrome'
[patent_app_type] => utility
[patent_app_number] => 13/541232
[patent_app_country] => US
[patent_app_date] => 2012-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16602
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13541232
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/541232 | Methods and Compositions for Monitoring and Risk Prediction in Cardiorenal Syndrome | Jul 2, 2012 | Abandoned |
Array
(
[id] => 9643395
[patent_doc_number] => 20140221507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-07
[patent_title] => 'Biomarker of Renal Impairment'
[patent_app_type] => utility
[patent_app_number] => 14/131212
[patent_app_country] => US
[patent_app_date] => 2012-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 18340
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14131212
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/131212 | Biomarker of Renal Impairment | Jul 1, 2012 | Abandoned |
Array
(
[id] => 8453172
[patent_doc_number] => 20120264118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-18
[patent_title] => 'Quantitation of Cellular DNA and Cell Numbers Using Element Labeling'
[patent_app_type] => utility
[patent_app_number] => 13/537386
[patent_app_country] => US
[patent_app_date] => 2012-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8121
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13537386
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/537386 | Quantitation of cellular DNA and cell numbers using element labeling | Jun 28, 2012 | Issued |
Array
(
[id] => 9581968
[patent_doc_number] => 08771969
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-08
[patent_title] => 'Peptide antibody depletion and its application to mass spectrometry sample preparation'
[patent_app_type] => utility
[patent_app_number] => 13/536047
[patent_app_country] => US
[patent_app_date] => 2012-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 14077
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13536047
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/536047 | Peptide antibody depletion and its application to mass spectrometry sample preparation | Jun 27, 2012 | Issued |
Array
(
[id] => 8870559
[patent_doc_number] => 08465935
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-18
[patent_title] => 'Detection and quantitation of cyclodextrins'
[patent_app_type] => utility
[patent_app_number] => 13/536069
[patent_app_country] => US
[patent_app_date] => 2012-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4573
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13536069
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/536069 | Detection and quantitation of cyclodextrins | Jun 27, 2012 | Issued |
Array
(
[id] => 8522670
[patent_doc_number] => 20120322079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-20
[patent_title] => 'METHOD FOR TESTING OR SCREENING PROTEIN SYNTHESIS INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/534942
[patent_app_country] => US
[patent_app_date] => 2012-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17360
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13534942
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/534942 | Method for testing or screening protein synthesis inhibitors | Jun 26, 2012 | Issued |
Array
(
[id] => 10831050
[patent_doc_number] => 08859215
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-14
[patent_title] => 'Cell binding assay'
[patent_app_type] => utility
[patent_app_number] => 14/129778
[patent_app_country] => US
[patent_app_date] => 2012-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2039
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14129778
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/129778 | Cell binding assay | Jun 26, 2012 | Issued |
Array
(
[id] => 14248577
[patent_doc_number] => 10274485
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-04-30
[patent_title] => Method for detecting biomolecules
[patent_app_type] => utility
[patent_app_number] => 14/235598
[patent_app_country] => US
[patent_app_date] => 2012-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 4415
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14235598
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/235598 | Method for detecting biomolecules | Jun 26, 2012 | Issued |
Array
(
[id] => 9463286
[patent_doc_number] => 20140127713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-08
[patent_title] => 'MEANS FOR THE EXAMINATION OF BODY FLUIDS'
[patent_app_type] => utility
[patent_app_number] => 14/125100
[patent_app_country] => US
[patent_app_date] => 2012-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3014
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14125100
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/125100 | MEANS FOR THE EXAMINATION OF BODY FLUIDS | Jun 3, 2012 | Abandoned |
Array
(
[id] => 9710554
[patent_doc_number] => 08835122
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-16
[patent_title] => 'Methods and system for the automated determination of immunofluorescent foci using a cell-based immunofluorescence assay using synthetic calibration particles'
[patent_app_type] => utility
[patent_app_number] => 14/124660
[patent_app_country] => US
[patent_app_date] => 2012-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7907
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14124660
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/124660 | Methods and system for the automated determination of immunofluorescent foci using a cell-based immunofluorescence assay using synthetic calibration particles | Jun 3, 2012 | Issued |
Array
(
[id] => 9656792
[patent_doc_number] => 20140227797
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-14
[patent_title] => 'DIAGNOSTIC USE OF PROSOMATOSTATIN'
[patent_app_type] => utility
[patent_app_number] => 14/124180
[patent_app_country] => US
[patent_app_date] => 2012-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9913
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14124180
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/124180 | DIAGNOSTIC USE OF PROSOMATOSTATIN | May 30, 2012 | Abandoned |
Array
(
[id] => 10240970
[patent_doc_number] => 20150125964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-07
[patent_title] => 'Detection of Diagnostic Peptides'
[patent_app_type] => utility
[patent_app_number] => 14/122349
[patent_app_country] => US
[patent_app_date] => 2012-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3393
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14122349
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/122349 | Detection of diagnostic peptides | May 22, 2012 | Issued |
Array
(
[id] => 9561171
[patent_doc_number] => 20140178884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-26
[patent_title] => 'METHOD OF DIAGNOSING AND TREATING AN ASPERGILLUS SPECIES-ASSOCIATED CONDITION'
[patent_app_type] => utility
[patent_app_number] => 14/118502
[patent_app_country] => US
[patent_app_date] => 2012-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 31453
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14118502
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/118502 | METHOD OF DIAGNOSING AND TREATING AN ASPERGILLUS SPECIES-ASSOCIATED CONDITION | May 21, 2012 | Abandoned |
Array
(
[id] => 8566502
[patent_doc_number] => 20120329072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-27
[patent_title] => 'Modification-Dependent Activity Assays'
[patent_app_type] => utility
[patent_app_number] => 13/475634
[patent_app_country] => US
[patent_app_date] => 2012-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 30051
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13475634
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/475634 | Modification-dependent activity assays | May 17, 2012 | Issued |
Array
(
[id] => 12173098
[patent_doc_number] => 09891234
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-13
[patent_title] => 'Biochemical markers for CVD risk assessment'
[patent_app_type] => utility
[patent_app_number] => 14/116924
[patent_app_country] => US
[patent_app_date] => 2012-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 10
[patent_no_of_words] => 12110
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14116924
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/116924 | Biochemical markers for CVD risk assessment | May 3, 2012 | Issued |